Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
Hand-out
Press Releases
March 26, 2025

Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million

$2,000,000 Direct-to-Phase 2 Award Funds Study of LNS8801 in the Treatment of Melanoma

bradford

The Bradford Era

More by this Author
Local & Social